STOCK TITAN

Director Stephen B. Burke defers JPM (NYSE: JPM) board retainer into stock grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

JPMorgan Chase & Co. director Stephen B. Burke reported a routine equity compensation transaction. He received 171.8449 shares of common stock on June 30, 2026 at $327.3300 per share as a grant or other acquisition, reflecting deferral of his quarterly director retainer into stock.

Following this award, he directly holds 208,303.1020 shares of common stock and indirectly holds 55,245 shares through a GRAT. The filing shows no open-market purchases or sales, only compensation-related and holding entries.

Positive

  • None.

Negative

  • None.

Insights

Routine director fee deferral into JPMorgan stock, no open-market trading.

Director Stephen B. Burke received 171.8449 JPMorgan common shares at $327.3300 per share as a grant or other acquisition. A footnote explains this reflects deferral of his quarterly retainer, payable in stock after his board service ends.

This is standard board compensation, not an open-market buy or sell, so it carries weak signaling value about his short-term view of the shares. After this transaction, he directly owns 208,303.1020 shares and indirectly 55,245 shares via a GRAT, indicating a substantial continuing equity stake.

Insider BURKE STEPHEN B
Role null
Type Security Shares Price Value
Grant/Award Common Stock 171.845 $327.33 $56K
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 208,303.102 shares (Direct, null); Common Stock — 55,245 shares (Indirect, By GRAT)
Footnotes (1)
  1. [object Object]
Stock grant size 171.8449 shares Common Stock grant/award on June 30, 2026
Grant price $327.3300 per share Price for June 30, 2026 stock award
Direct holdings after transaction 208,303.1020 shares Common Stock directly owned following June 30, 2026 grant
Indirect holdings via GRAT 55,245 shares Common Stock held indirectly by GRAT as of June 30, 2026
GRAT financial
"indirectly holds 55,245 shares through a GRAT"
quarterly retainer financial
"Deferral of quarterly retainer, payable in common stock"
grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
BURKE STEPHEN B

(Last)(First)(Middle)
270 PARK AVENUE

(Street)
NEW YORK NEW YORK 10017-2014

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
JPMORGAN CHASE & CO [ JPM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/30/2026A(1)171.8449A$327.33208,303.102D
Common Stock55,245IBy GRAT
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Deferral of quarterly retainer, payable in common stock following termination of service as director.
Remarks:
poaburke.txt
/s/ Denise G. Connors under POA07/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did JPM director Stephen B. Burke report in this Form 4 for JPM?

Stephen B. Burke reported receiving 171.8449 JPMorgan common shares as a grant or other acquisition. The award reflects deferral of his quarterly director retainer into stock, rather than an open-market purchase or sale, making it routine compensation-related activity.

Was the JPM Form 4 filing for Stephen B. Burke a stock buy or sell?

The filing does not show any open-market buys or sells by Stephen B. Burke. It records a grant or other acquisition of 171.8449 common shares tied to deferred director fees, along with a separate holding entry for shares owned indirectly through a GRAT.

How many JPM shares does Stephen B. Burke hold after this Form 4 transaction?

After the reported grant, Stephen B. Burke directly holds 208,303.1020 JPMorgan common shares. He also indirectly holds 55,245 shares through a GRAT, giving him a sizeable disclosed equity interest across both direct and indirect ownership categories.

What price is associated with Stephen B. Burke’s JPM stock grant on June 30, 2026?

The grant to Stephen B. Burke is recorded at a price of $327.3300 per JPMorgan common share. This price is used for the 171.8449-share award that represents deferral of his quarterly retainer into stock-based compensation.

What does the GRAT reference mean in Stephen B. Burke’s JPM holdings?

The filing shows 55,245 JPMorgan shares held indirectly “By GRAT,” referring to a grantor retained annuity trust. This entity holds shares associated with Burke, separate from his 208,303.1020 directly owned shares reported after the June 30, 2026 transaction.